Genesis Healthcare Settles Insider Dispute, Unsecured Creditors to Get $150M Cash
GENNQ filed a Legal and Risk Events on elevated volume (5.4× avg).
Summary
Genesis Healthcare settled a dispute with controlling investor Joel Landau, clearing a major obstacle to its chapter 11 plan confirmation. The deal includes a $150 million cash contribution to the bankruptcy estate for unsecured creditors, plus waivers of over $100 million in secured term-loan claims and several hundred million in general unsecured claims. Unsecured creditor recoveries jump from an expected $15 million to hundreds of millions, a dramatic improvement for former residents and families holding personal injury claims. The settlement, confirmed in court by lawyers for both sides, paves the way for a consensual plan confirmation scheduled for October. This resolves a contentious trial over a $450 million claim that had threatened to derail the restructuring.
At the time of this announcement, GENNQ was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $8.2M. The 52-week trading range was $0.00 to $0.30. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.